Comprehensive Evaluation of Caregiver-Reported Antiretroviral Therapy Adherence for HIV-Infected Children
- 266 Downloads
For HIV-infected children, adherence to antiretroviral therapy (ART) is often assessed by caregiver report but there are few data on their validity. We conducted prospective evaluations with 191 children ages 0–14 years and their caregivers over 6 months in western Kenya to identify questionnaire items that best predicted adherence to ART. Medication Event Monitoring Systems® (MEMS, MWV/AARDEX Ltd., Switzerland) electronic dose monitors were used as external criterion for adherence. We employed a novel variable selection tool using the LASSO technique with logistic regression to identify items best correlated with dichotomized MEMS adherence (≥90 or <90 % doses taken). Nine of 48 adherence items were identified as the best predictors of adherence, including missed or late doses in the past 7 days, problems giving the child medicines, and caregiver-level factors like not being present at medication taking. These items could be included in adherence assessment tools for pediatric patients.
KeywordsPediatric HIV care Adherence Best practice Resource-limited setting
We would first and foremost like to thank the Kenyan families who took part in this study. We would also like to acknowledge the significant work of key clinicians and nurses at AMPATH in promoting and helping evaluate adherence, including Irene Marete, Edith Apondi, Peter Gisore, Constance Tenge, Esther Nabakwe, John Chumba, Lucy Warui, Mary Rugut, Victor Cheboi, and Christine Mukhwana. This research was supported in part by a Grant (1K23MH087225) to Dr. Vreeman from the NIMH and AMPATH Plus with support from the United States Agency for International Development as part of the President’s Emergency Plan for AIDS Relief (PEPFAR).
Conflict of interest
The authors have no conflicts of interest to disclose.
- 1.World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access—progress report 2011. Geneva: World Health Organization; 2011.Google Scholar
- 10.San-Andres FJ, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989–1997. Clin Infect Dis. 2003;36(9):1177–85.CrossRefPubMedGoogle Scholar
- 14.Vreeman RC, Nyandiko WM, Blaschke TF. Adherence to antiretroviral therapy for adults and children in resource-limited settings. Rev Antivir Ther. 2009;2(Suppl):S6–13.Google Scholar
- 17.Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003;33(2):211–8.CrossRefPubMedGoogle Scholar
- 24.Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156(11):817–33.CrossRefPubMedCentralPubMedGoogle Scholar
- 31.Tibshirani R. Regression shrinkage and selection via the LASSO. J R Stat Soc Ser B. 1996;58(1):267–88.Google Scholar
- 39.WHO. WHO Global Database on Child Growth and Malnutrition. Geneva: World Health Organization; 1997.Google Scholar
- 42.Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV/AIDS Res Palliat Care. 2013;5:1–17.Google Scholar